Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P00790 (
PGA
)
2,475
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The binding sites for methylfolate of the
FABP
in serum are fully saturated in the physiological state. When the
FABP
of serum from pregnant subjects is stripped of its endogenous folate, it is capable of binding an average of 549 +/- 12 pg/ml (range 464 to 723) of 14C-methylfolate, compared with 736 +/- 57 pg/ml (range 491 to 1610) of 3H-
PGA
. When 3H-
PGA
is added to untreated serum, an average of 258 +/- 6 pg/ml (range 218 to 325) is bound by
FABP
; this binding represents sites available to
PGA
but not to methylfolate, as well as sites from which methylfolate is displaced by 3H-
PGA
. This displacement averages 71 +/- 10 pg/ml (range 9 to 142), the amount which the standard technique for measurement of the UFBC for 3H-
PGA
overestimates the true UFBC for
PGA
.
...
PMID:Binding of methylfolate and pteroylglutamic acid by the specific serum folate binder. 42 35
Liver fatty acid binding protein (L-FABP) is the principal target protein of the hepatic carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene) in rat liver. In addition, the cyclopentenone prostaglandins (PG),
PGA
, PGJ2, and delta 12-PGJ2, inhibit the growth of many cell types in vitro. This report describes the preferential binding of the growth inhibitory prostaglandins by L-
FABP
and the reversible inhibition of thymidine incorporation into DNA by PGA2 and delta 12-PGJ2 in primary cultures of purified rat hepatocytes. As a model ligand, [3H]PGA1 bound to L-
FABP
specifically, reversibly, rapidly, and with high affinity. Its dissociation constants were 134 nM (high affinity) and 3.6 microM (low affinity). The high-affinity binding of [3H]PGA1 was 9- and approximately 13-fold more avid than the binding of the conventional fatty acid ligands, oleic acid and arachidonic acid, respectively. The abilities of different prostaglandins to compete with the high-affinity binding of [3H]PGA1 correlated with their growth inhibitory activities reported previously and here. The growth inhibitory cyclopentenone prostaglandins (PGA1, PGA2, delta 12-PGJ2, and PGJ2) were the best competitive ligands, intermediate competitors were the weak growth inhibitors PGE1 and PGD2, and the poorest competitors were PGE2 and PGF2 alpha, which stimulate rather than inhibit DNA synthesis in rat hepatocytes in primary culture. The in vitro actions of L-FABP are compatible with those of a specific and dissociable carrier of growth inhibitory prostaglandins in rat hepatocytes and suggest that the carcinogen may usurp the cellular machinery of the growth inhibitory prostaglandins.
...
PMID:Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. 225 Dec 82